Position in NTRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$793,991
+$196,221 QoQ
Shares Held
2,925
-2.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#465
of 844 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 73%
Shared 0%
None 27%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026COLDSTREAM CAPITAL MANAGEMENT INC holds $19,434,172 across 15 Diagnostics & Research names. NTRA ranks #6 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
11,059 | $5,544,539 | |
| 2 | DHR |
Danaher Corp /De/
|
16,046 | $3,056,442 | |
| 3 | DGX |
Quest Diagnostics Inc
|
13,668 | $2,896,932 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
2,020 | $1,063,408 | |
| 5 | WAT |
Waters Corp /De/
|
2,745 | $1,029,484 | |
| 6 | NTRA |
Natera, Inc.
This page
|
2,925 | $793,991 | |
| 7 | ILMN |
Illumina, Inc.
|
4,401 | $773,827 | |
| 8 | A |
Agilent Technologies, Inc.
|
5,757 | $764,702 |
All Filings in NTRA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $793,991 | 2,925 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $597,770 | 2,989 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $433,896 | 1,894 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $493,534 | 3,066 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $481,310 | 2,849 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $342,495 | 2,422 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $377,703 | 2,386 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $297,951 | 2,347 | Shares | Sole | 2024-11-18 | |
| No filing history on record for this holder in this stock. | ||||||